Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells

dc.contributor.authorQueiroz, Alexandre Flavio Silva de
dc.contributor.authorSilva, Rodrigo A.
dc.contributor.authorMoura, Raniere M.
dc.contributor.authorDreyfuss, Juliana L.
dc.contributor.authorParedes-Gamero, Edgar J.
dc.contributor.authorSouza, Ana C. S.
dc.contributor.authorTersariol, Ivarne L. S.
dc.contributor.authorSantos, Elizeu A.
dc.contributor.authorNader, Helena B.
dc.contributor.authorJusto, Giselle Z.
dc.contributor.authorSales, Maurício P. de
dc.date.accessioned2018-05-26T15:57:42Z
dc.date.available2018-05-26T15:57:42Z
dc.date.issued2008-09-10
dc.description.resumoPurpose In this study, the antitumoral potential of a novel lectin (CvL) puriWed from the marine sponge Cliona varians was studied in diVerent cancer cell lines. Methods CvL cytotoxicity was evaluated in mammalian tumor cells and in normal human peripheral blood lymphocytes by the MTT assay using the same range of concentrations (1–150 _g ml¡1). The mechanisms involved in K562 cell death were investigated by confocal Xuorescence microscopy, Xow cytometry and immunoblot. Results CvL inhibited the growth of human leukemia cells, with IC50 values of 70 and 100 _gml¡1 for K562 and JURKAT cells, respectively, but it was ineVective on blood lymphocytes and solid tumor cell lines. K562 cell death occurred 72 h after exposure to the lectin and with signs of apoptosis, as analyzed by DAPI and annexin V/PI staining. Investigation of the possible mediators of this process showed that cell death occurred via a caspase-independent pathway. Confocal Xuorescence microscopy indicated a pivotal role for the lysosomal protease cathepsin B in mediating cell death. Accordingly, pre-incubation of K562 cells with the cathepsin inhibitor L-trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64) abolished CvL cytotoxic eVect. Furthermore, we found upregulation of tumor necrosis factor receptor 1 (TNFR1) and down-modulation of p65 subunit of nuclear factor kappa B (NF_B) expression in CvL-treated cells. These eVects were accompanied by increased levels of p21 and reduced expression of pRb, suggesting that CvL can induce cell cycle arrest. Conclusions Collectively, these Wndings indicate an antileukemic eVect for CvL and suggest that cathepsin B acts as a death mediator in CvL-induced cytotoxicity possibly in an uncharacterized connection with the membrane death receptor pathway.pt_BR
dc.identifier.citationQueiroz,Alexandre F. S.; Silva, Rodrigo A.;Moura, Raniere M.;Dreyfuss, Juliana L.;Paredes-Gamero, Edgar J.; Souza, Ana C. S.; Tersariol, Ivarne L. S.; Santos, Elizeu A.; Nader.Helena B.; Justo, Giselle Z.; Sales, Maurício P. de.Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.Cancer Chemotherapy and Pharmacology, v. 63, p. 1023-1033, 2009.Disponível em: <https://link.springer.com/article/10.1007/s00280-008-0825-4>. Acesso em: 05 mar. 2018.pt_BR
dc.identifier.doi10.1007/s00280-008-0825-4
dc.identifier.issn1432-0843
dc.identifier.urihttps://repositorio.ufrn.br/jspui/handle/123456789/25250
dc.languageengpt_BR
dc.publisherSpringerpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectLectinpt_BR
dc.subjectCliona varianspt_BR
dc.subjectK562pt_BR
dc.subjectApoptosispt_BR
dc.subjectCathepsin Bpt_BR
dc.subjectCytotoxicitypt_BR
dc.subjectAntitumorpt_BR
dc.titleGrowth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cellspt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
GrowthInhibitoryActivity_Queiroz_2008.pdf
Tamanho:
505.9 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar